1
|
Tsehay M, Belete A, Necho M. Epidemiology and associated factors of depression among cancer patients in Ethiopia: protocol for systematic review and meta-analysis. Int J Ment Health Syst 2022; 16:46. [PMID: 36056363 PMCID: PMC9438069 DOI: 10.1186/s13033-022-00556-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/12/2021] [Accepted: 08/25/2022] [Indexed: 11/25/2022] Open
Abstract
Background There is no pooled evidence regarding the prevalence and potential associated factors of depression among cancer patients in Ethiopian community. Hence, the current review aimed to examine the prevalence and associated factors of depression among cancer patients in Ethiopia. Method A computerized systematic literature search was made in MEDLINE, Scopus, PubMed, Science Direct, and Google Scholar. Each database was searched from its start date to June 2020. More over we will also add scholars and gray literature consultations. All articles will be included if they were published in English, which evaluated the prevalence and associated factors of depression among cancer patients in Ethiopia. Pooled estimations with a 95% confidence interval (CI) were calculated with DerSimonian-Laird random-effects model. Publication bias was evaluated by using inspection of funnel plots and statistical tests. Discussion Since we are using existing anonymized data, ethical approval is not required for this study. Our results can be used to guide clinical decisions about the most efficient way to prevent and treat depression among cancer patients. Systematic review registration Submitted to Prospero.
Collapse
Affiliation(s)
- Mekonnen Tsehay
- College of Medicine and Health Sciences, Department of Psychiatry, Wollo University, Dessie, Ethiopia.
| | - Asmare Belete
- College of Medicine and Health Sciences, Department of Psychiatry, Wollo University, Dessie, Ethiopia
| | - Mogesie Necho
- College of Medicine and Health Sciences, Department of Psychiatry, Wollo University, Dessie, Ethiopia
| |
Collapse
|
2
|
Arian M, Vaismoradi M, Badiee Z, Soleimani M. Understanding the impact of COVID-19 pandemic on health-related quality of life amongst Iranian patients with beta thalassemia major: a grounded theory. Prim Health Care Res Dev 2021; 22:e67. [PMID: 34753533 PMCID: PMC8581459 DOI: 10.1017/s146342362100013x] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2020] [Revised: 01/28/2021] [Accepted: 02/09/2021] [Indexed: 12/04/2022] Open
Abstract
BACKGROUND The coronavirus disease 2019 (COVID-19) pandemic and the resulting measures can impact daily life and healthcare management amongst patients with beta thalassemia major. METHODS The Corbin and Strauss method of grounded theory was used to explore the impact of the COVID-19 pandemic on health-related quality of life (HRQoL) amongst Iranian patients with beta thalassemia major. Semi-structured interviews with 16 patients with thalassemia major in the eastern of Iran were performed. Data collection was conducted from 19 September through 18 November 2020. Collected data were recorded, transcribed, and coded to develop themes and subthemes. Paradigm components were sought to find out what happened to these patients and explore the process and events. RESULTS Insights from these interviews led to five major themes: 'changing physical health', 'emotional and psychological reactions', 'changing the nature of relationships and the scope of social support', 'metamorphosis of ongoing healthcare, and 'functionality and adaptation to new realities.' The emerging core concept was labelled: 'maintaining well-being balance.' The COVID-19 pandemic disturbed the balance of life and health of the patients. Multiple strategies to maintain balance and reduce the negative effects of the COVID-19 pandemic on HRQoL were used by the patients, the healthcare team, and support systems. CONCLUSIONS Due to the fear of COVID-19, the patients with beta thalassemia were less likely to contact healthcare professionals. They considered postponing blood transfusion and abandoned evaluating disease complications. Reduced access to the healthcare system and shifting resources from existing programmes to COVID-19 by the healthcare system were incompatible policies. These policies and strategies had strong and negative effects on the physical domain of HRQoL. The patients experienced a deterioration of emotional functioning. They reported a strong reduction in social functioning and felt lonely. Online interventions supporting mental health and social interactions and telemedicine can help during the times of social distancing and lockdowns.
Collapse
Affiliation(s)
- Mahdieh Arian
- Student Research Committee, Faculty of Nursing and Midwifery, Semnan University of Medical Sciences, Semnan, Iran
| | | | - Zahra Badiee
- Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mohsen Soleimani
- Nursing Care Research Center, Faculty of Nursing and Midwifery, Semnan University of Medical Sciences, Semnan, Iran
| |
Collapse
|
3
|
Ciążyńska M, Pabianek M, Szczepaniak K, Ułańska M, Skibińska M, Owczarek W, Narbutt J, Lesiak A. Quality of life of cancer patients during coronavirus disease (COVID-19) pandemic. Psychooncology 2020; 29:1377-1379. [PMID: 32779778 PMCID: PMC7323427 DOI: 10.1002/pon.5434] [Citation(s) in RCA: 59] [Impact Index Per Article: 14.8] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2020] [Revised: 05/18/2020] [Accepted: 05/19/2020] [Indexed: 12/14/2022]
Affiliation(s)
- Magdalena Ciążyńska
- Department of Proliferative Diseases, Nicolaus Copernicus Multidisciplinary Centre for Oncology and Traumatology, Łódź, Poland
| | - Marta Pabianek
- Department of Proliferative Diseases, Nicolaus Copernicus Multidisciplinary Centre for Oncology and Traumatology, Łódź, Poland
| | - Katarzyna Szczepaniak
- Department of Proliferative Diseases, Nicolaus Copernicus Multidisciplinary Centre for Oncology and Traumatology, Łódź, Poland
| | - Małgorzata Ułańska
- Department of Proliferative Diseases, Nicolaus Copernicus Multidisciplinary Centre for Oncology and Traumatology, Łódź, Poland
| | - Małgorzata Skibińska
- Department of Dermatology, Paediatric Dermatology and Oncology Clinic, Medical University of Łódź, Łódź, Poland
| | - Witold Owczarek
- Dermatology Clinic, Military Institute of Medicine in Warsaw, Warsaw, Poland
| | - Joanna Narbutt
- Department of Dermatology, Paediatric Dermatology and Oncology Clinic, Medical University of Łódź, Łódź, Poland
| | - Aleksandra Lesiak
- Department of Dermatology, Paediatric Dermatology and Oncology Clinic, Medical University of Łódź, Łódź, Poland
| |
Collapse
|
4
|
Zhu J, Hussain M, Joshi A, Truica CI, Nesterova D, Collins J, Saunders EFH, Hayes M, Drabick JJ, Joshi M. Effect of creative writing on mood in patients with cancer. BMJ Support Palliat Care 2019; 10:64-67. [PMID: 30824430 DOI: 10.1136/bmjspcare-2018-001710] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2018] [Revised: 01/29/2019] [Accepted: 02/11/2019] [Indexed: 11/04/2022]
Abstract
OBJECTIVE To determine the feasibility of conducting creative writing workshops (CWW) for patients with cancer to promote improvement in mood. METHOD We piloted a prospective study to determine the feasibility of conducting CWW over a 4-week period. Patients were randomised 2:1 to either an intervention arm (IA) or to standard of care (SOC). Patients in the IA attended four 2-hour long weekly CWW × 4 weeks, whereas those receiving SOC did not participate in the CWW. We used a validated emotion thermometer scale (ETS) to assess changes in patient's mental health before and after intervention. Patients with metastatic or unresectable cancer were included. PRIMARY ENDPOINT: (1) Feasibility and (2) mood scores before and after CWW using ETS. RESULTS A total of 16 patients were enrolled: 11 in the IA vs 5 in SOC. Seven out of 11 (63%) patients enrolled in the IA attended at least 75% of classes. Patients in the IA showed a trend towards mood improvement relative to the SOC when comparing initial and final ETS scores. Within the IA group significantly lower postclass total ETS scores were observed relative to preclass ETS scores. Also, a significant decreasing trend over time was observed in the preclass total ETS scores for participants in the IA group. CONCLUSIONS It is feasible for patients with cancer to attend CWW. Our results also show a positive effect on mood in the CWW arm. Further prospective clinical studies are needed to evaluate the effect of this intervention in patients with cancer.
Collapse
Affiliation(s)
- Junjia Zhu
- Public Health Sciences, Penn State Cancer Institute, Hershey, Pennsylvania, USA
| | - Muhammad Hussain
- Medicine, Penn State Cancer Institute, Hershey, Pennsylvania, USA.,New York Oncology Hematology PC, Albany, New York, USA
| | - Aditya Joshi
- Department of Psychiatry, Penn State, Hershey, Pennsylvania, USA
| | | | - Darya Nesterova
- Neurosurgery, Penn State College of Medicine, Hershey, Pennsylvania, USA
| | - Jolene Collins
- Medicine, Penn State Cancer Institute, Hershey, Pennsylvania, USA
| | | | - Michael Hayes
- Medicine, Penn State Cancer Institute, Hershey, Pennsylvania, USA.,Department of Psychiatry, Penn State, Hershey, Pennsylvania, USA
| | - Joseph J Drabick
- Medicine, Penn State Cancer Institute, Hershey, Pennsylvania, USA
| | - Monika Joshi
- Medicine, Penn State Cancer Institute, Hershey, Pennsylvania, USA
| |
Collapse
|
5
|
Chen AM, Hsu S, Felix C, Garst J, Yoshizaki T. Effect of psychosocial distress on outcome for head and neck cancer patients undergoing radiation. Laryngoscope 2017; 128:641-645. [PMID: 28714543 DOI: 10.1002/lary.26751] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2017] [Revised: 05/06/2017] [Accepted: 05/30/2017] [Indexed: 01/06/2023]
Abstract
OBJECTIVES/HYPOTHESIS To determine the impact of pretreatment psychosocial distress on compliance to radiation therapy (RT) and clinical outcomes for patients with head and neck cancer STUDY DESIGN: Self-reported responses to the mood and anxiety domains of the University of Washington Quality of Life instrument were reviewed among 133 patients with newly diagnosed head and neck cancer prior to initiating RT. METHODS Varying definitions were used (total number of unexpectedly missed RT days, >5 days continuous interruption of RT outside of weekends, >10 days continuous interruption of RT, and failure to complete prescribed course of RT) to analyze the effect of psychosocial disruption on compliance. Survival was determined using the Kaplan-Meier method. RESULTS The prevalence of pretreatment depression and anxiety was 23% and 47%, respectively. Continuous RT breaks >5 days occurred in 46%, 33%, 10%, 9%, and 0% of patients whose mood was rated as "extremely depressed," "somewhat depressed," "neither in a good mood or depressed," "generally good," and "excellent," respectively (P = .0016). The corresponding proportion of patients who did not complete their planned RT was 23%, 11%, 5%, and 3%, and 0%, respectively (P = .043). The 2-year overall survival of patients who were "extremely depressed" or "somewhat depressed" at baseline was 71% versus 86% for all others (P = .026). Depression was independently associated with decreased overall survival on logistical regression analysis. CONCLUSIONS Pretreatment depression predicted for decreased RT compliance and inferior survival for head and neck cancer. Additional research to overcome potential barriers to treatment in this setting may be warranted. LEVEL OF EVIDENCE 4. Laryngoscope, 128:641-645, 2018.
Collapse
Affiliation(s)
- Allen M Chen
- Department of Radiation Oncology, University of California, Los Angeles-David Geffen School of Medicine, Los Angeles, California, U.S.A
| | - Sophia Hsu
- Department of Radiation Oncology, University of California, Los Angeles-David Geffen School of Medicine, Los Angeles, California, U.S.A
| | - Care Felix
- Department of Radiation Oncology, University of California, Los Angeles-David Geffen School of Medicine, Los Angeles, California, U.S.A
| | - Jordan Garst
- Department of Radiation Oncology, University of California, Los Angeles-David Geffen School of Medicine, Los Angeles, California, U.S.A
| | - Taeko Yoshizaki
- Department of Radiation Oncology, University of California, Los Angeles-David Geffen School of Medicine, Los Angeles, California, U.S.A
| |
Collapse
|
6
|
Loeve S. Of drug administration, war and oïkos: mediating cancer with nanomedicines. Nanomedicine (Lond) 2015; 10:3261-74. [PMID: 26470679 DOI: 10.2217/nnm.15.161] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
This paper focuses on nano-enabled drug delivery systems (NDDS) in the context of cancer medicine. It regards NDDS as relational objects whose modes of existence are defined by their relationships with a complex biocultural environment that includes both the biological processes of our bodies and the values representations and metaphors our societies associate with cancer and cancer therapy. Within this framework the abundant use of war metaphors in NDDS --from 'smart bombs' to 'magic nano-bullets'--is discussed from various angles: in terms of therapeutic efficacy, it limits the potential of the technique by preventing the inclusion of the (patho)biological environment in the nanomedicine's mode of action. In terms of development opportunities, the military strategy of active specific targeting faces cost and complexity bottlenecks. In terms of ethical values, it favors the questionable image of cancer patients as 'fighters'. On the basis of these criticisms different metaphorical frameworks are suggested, in particular that of oïkos, whereby nanomedicine is reframed as a kind of domestic economy addressing the system-environment relationships of embodied processes with further imagination and care.
Collapse
Affiliation(s)
- Sacha Loeve
- COSTECH lab., Compiègne University of Technology, Centre Pierre Guillaumat, BP 60319, 60203 Compiègne, France
| |
Collapse
|
7
|
Smith HR. Depression in cancer patients: Pathogenesis, implications and treatment (Review). Oncol Lett 2015; 9:1509-1514. [PMID: 25788991 PMCID: PMC4356432 DOI: 10.3892/ol.2015.2944] [Citation(s) in RCA: 215] [Impact Index Per Article: 23.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2014] [Accepted: 02/02/2015] [Indexed: 12/14/2022] Open
Abstract
Depression is a common comorbidity in cancer cases, affecting >10% of patients. A cancer diagnosis is life-changing, and is a source of considerable psychological and emotional stress. Non-pathological sadness may be a normal response to a cancer diagnosis, however, stress beyond the coping mechanisms of patients may result in major depressive disorder. The current review, in addition to the obvious psychosocial elements of depression, explores its biological mechanisms, including tissue damage, inflammatory mediators and the chronic stress response, and how these immune and endocrine pathways may underlie depression in cancer. Possible iatrogenic causes of depression in cancer are also explored. There is a strong need to identify and treat depression in cancer patients in order to increase quality of life and reduce mortality. The most popular clinical and potential future biochemical screening tools for depression in cancer are briefly discussed. The interventions used will vary for every patient, but may include psychosocial therapies or pharmacotherapy; however, a paucity of research on the most effective management of depression in cancer means the optimal combination of therapies is unknown. Selection of antidepressants should be carefully considered, given the common side effects of chemotherapy (such as nausea), and the necessity to avoid serious interactions, including reducing the effectiveness of chemotherapeutic drugs. The possible link between the chronic stress response, which may predispose patients to depression, and the risk of mortality from cancer is also explored. The complex interactions between the endocrine, nervous and immune systems, which continue to be elucidated, may offer the opportunity for the development of more rapid and efficacious treatments for depression in cancer in the future.
Collapse
Affiliation(s)
- Hamish R Smith
- School of Medicine and Dentistry, James Cook University, Townsville, Queensland 4811, Australia
| |
Collapse
|
8
|
Mustafa M, Carson‐Stevens A, Gillespie D, Edwards AGK. Psychological interventions for women with metastatic breast cancer. Cochrane Database Syst Rev 2013; 2013:CD004253. [PMID: 23737397 PMCID: PMC11032751 DOI: 10.1002/14651858.cd004253.pub4] [Citation(s) in RCA: 55] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
BACKGROUND Psychological symptoms are associated with metastatic breast cancer. This is the basis for exploring the impact of psychological interventions on psychosocial and survival outcomes. One early study appeared to show significant survival and psychological benefits from psychological support while subsequent studies have revealed conflicting results. This review is an update of a Cochrane review first published in 2004 and previously updated in 2007. OBJECTIVES To assess the effects of psychological interventions on psychosocial and survival outcomes for women with metastatic breast cancer. SEARCH METHODS We searched the Cochrane Breast Cancer Group Specialised Register, MEDLINE (OvidSP), EMBASE (OvidSP), PsycINFO (OvidSP), CINAHL (EBSCO), online trials and research registers in June/July 2011. Further potentially relevant studies were identified from handsearching references of previous trials, systematic reviews and meta-analyses. SELECTION CRITERIA Randomised controlled trials (RCTs) and cluster RCTs of psychological interventions, which recruited women with metastatic breast cancer. Outcomes selected for analyses were overall survival, psychological outcomes, pain, quality of life, condition-specific outcome measures, relationship and social support measures, and sleep quality. Studies were excluded if no discrete data were available on women with metastatic breast cancer. DATA COLLECTION AND ANALYSIS Two review authors independently extracted the data and assessed the quality of the studies using the Cochrane Collaboration risk of bias tool. Where possible, authors were contacted for missing information. Data on the nature and setting of the intervention, relevant outcome data, and items relating to methodological quality were extracted. Meta-analyses was performed using a random-effects or fixed-effect Mantel-Haenszel model, depending on expected levels of heterogeneity. MAIN RESULTS Ten RCTs with 1378 women were identified. Of the seven RCTs on group psychological interventions, three were on cognitive behavioural therapy and four were on supportive-expressive group therapy. The remaining three studies were individual based and the types of psychological interventions were not common to either cognitive behavioural or supportive-expressive therapy. A clear pattern of psychological outcomes could not be discerned as a wide variety of outcome measures and durations of follow-up were used in the included studies. The overall effect of the psychological interventions across six studies, on one-year survival, favoured the psychological intervention group with an odds ratio (OR) of 1.46 (95% confidence interval (CI) 1.07 to 1.99). Pooled data from four studies did not show any survival benefit at five-years follow-up (OR 1.03, 95% CI 0.42 to 2.52). There was evidence of a short-term benefit for some psychological outcomes and improvement in pain scores. AUTHORS' CONCLUSIONS Psychological interventions appear to be effective in improving survival at 12 months but not at longer-term follow-up, and they are effective in reducing psychological symptoms only in some of the outcomes assessed in women with metastatic breast cancer. However, findings of the review should be interpreted with caution as there is a relative lack of data in this field, and the included trials had reporting or methodological weaknesses and were heterogeneous in terms of interventions and outcome measures.
Collapse
Affiliation(s)
- Mohammed Mustafa
- Cardiff UniversityCochrane Institute of Primary Care and Public Health, School of Medicine2nd Floor, Neuadd MeirionnyddHeath ParkCardiffWalesUKCF14 4YS
| | - Andrew Carson‐Stevens
- Cardiff UniversityCochrane Institute of Primary Care and Public Health, School of Medicine2nd Floor, Neuadd MeirionnyddHeath ParkCardiffWalesUKCF14 4YS
| | - David Gillespie
- Cardiff UniversitySouth East Wales Trials Unit, Institute of Translation, Innovation, Methods and Engagement4th Floor, Neuadd MeirionnyddHeath ParkCardiffWalesUKCF14 4YS
| | - Adrian GK Edwards
- Cardiff UniversityCochrane Institute of Primary Care and Public Health, School of Medicine2nd Floor, Neuadd MeirionnyddHeath ParkCardiffWalesUKCF14 4YS
| | | |
Collapse
|
9
|
Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients. Cancer 2009; 115:5349-61. [PMID: 19753617 DOI: 10.1002/cncr.24561] [Citation(s) in RCA: 638] [Impact Index Per Article: 42.5] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Affiliation(s)
- Jillian R Satin
- Department of Psychology, University of British Columbia, Vancouver, British Columbia, Canada.
| | | | | |
Collapse
|
10
|
Shiloh S, Peretz G, Iss R, Kiedan R. Recovery attributions: explicit endorsement of biomedical factors and implicit dominance of psycho-social factors. J Behav Med 2007; 30:243-51. [PMID: 17443403 DOI: 10.1007/s10865-007-9100-0] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2006] [Accepted: 03/19/2007] [Indexed: 11/25/2022]
Abstract
Two studies assessed lay people's bio-medical and psycho-social attributions for recovery, using implicit and explicit methods, and one of them, Study 2, also measured individual differences in health locus of control. Participants were presented with a vignette of a patient with a severe disease for which chances of recovery vary widely, who had high or low levels of medical care and high or low psycho-social resources. They estimated his chances to recover from his illness (implicit attributions), and then, imagining another patient with the same disease, evaluated the relative importance of medical, psycho-social and other factors for his chances for recovery (explicit method). Findings show a moderation effect by assessment method: the explicit method pointed to dominance of biomedical attributions and the implicit method indicated dominance of psycho-social attributions. In addition, internal health locus of control was positively correlated with psycho-social attributions and external health locus of control (powerful others and chance) was correlated with biomedical attributions for recovery. The findings are discussed in relation to dual-process models of reasoning and self-serving defensive processes.
Collapse
Affiliation(s)
- Shoshana Shiloh
- Department of Psychology, Gordon Faculty of Social Sciences, Tel Aviv University, Tel Aviv, Israel.
| | | | | | | |
Collapse
|
11
|
Coyne JC, Pajak TF, Harris J, Konski A, Movsas B, Ang K, Watkins Bruner D. Emotional well-being does not predict survival in head and neck cancer patients. Cancer 2007; 110:2568-75. [DOI: 10.1002/cncr.23080] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
12
|
Edelman S. Relationship between psychological factors and cancer: An update of the evidence. CLIN PSYCHOL-UK 2006. [DOI: 10.1080/13284200500221086] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- Sarah Edelman
- Health Psychology Unit, University of Technology , Sydney, New South Wales, Australia
| |
Collapse
|